JB Chemicals & Pharmaceuticals Q2 Results Live: Profit Rise by 15.92% YOY

JB Chemicals & Pharmaceuticals Q2 Results Live : JB Chemicals & Pharmaceuticals has announced its Q2 results for the fiscal year, revealing a notable increase in profits and revenue. The company declared its financial performance on November 6, 2024, showing a year-over-year revenue growth of 13.48% and a profit increase of 15.92%. However, compared to the previous quarter, the revenue saw a slight decline of 0.38%, and profit decreased by 1.28%.

The company's selling, general, and administrative expenses increased by 2.19% quarter-over-quarter and rose significantly by 15.03% year-over-year. This uptick in expenses has contributed to a decrease in operating income, which was down by 4.57% compared to the last quarter, although it still reflects an increase of 8.17% year-over-year.

Earnings per share (EPS) for the quarter stood at ₹11, marking a year-over-year increase of 15.3%. Despite the mixed results, JB Chemicals & Pharmaceuticals has shown resilience, with a -0.1% return in the last week, a 4.57% return over the past six months, and a robust 15.76% year-to-date return.

Currently, JB Chemicals & Pharmaceuticals boasts a market capitalization of ₹29,209.98 crore, with a 52-week high of ₹2030 and a low of ₹1371. The stock's performance has attracted attention from analysts, with 1 analyst giving a Strong Sell rating, 2 analysts recommending a Hold, 2 advising a Buy, and 6 providing a Strong Buy rating.

As of November 7, 2024, the consensus recommendation among analysts is to Buy, indicating a positive outlook for the company's future performance.